Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways-Reference-Cited by-同舟云学术

Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways

Published:2021-02-16 Issue:3 Volume:38 Page:1397-1403
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Mangia Alessandra^ORCID,Albanese Anthony P.,Bourliére Marc,Craxi Antonio,Dieterich Douglas,Solomon Sunil,Vanstraelen Kim,Hernandez Candido,Turnes Juan

Funder

Gilead Sciences

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-021-01636-7.pdf

Reference32 articles.

1. Pokorska-Śpiewak M, Śpiewak M. Management of hepatitis C in children and adolescents during COVID-19 pandemic. World J Hepatol. 2020;12:485–92.

2. Aghemo A, Masarone M, Montagnese S, et al. Assessing the impact of COVID-19 on the management of patients with liver diseases: a national study by the Italian Association of the Study of the Liver. Dig Liver Dis. 2020;52:937–41.

3. World Health Organization. Global health sector strategy on viral hepatitis 2016–21. https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/. Accessed Jan 2021.

4. Blach S, Kondili LA, Aghemo A, et al. Impact of COVID-19 on global HCV elimination efforts. J Hepatol. 2021;74:31–6.

5. Boettler T, Newsome PN, Mondelli MU, et al. Care of patients with liver disease during the COVID-19 pandemic: EASL-SECMID position paper. J Hep Rep. 2020;2:100113.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sofosbuvir and Velpatasvir Regimen Outcome for Chronic Hepatitis C Patients With End-Stage Renal Disease Undergoing Hemodialysis;Cureus;2023-09-21

2. Efficacy and safety of sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir for hepatitis C in Korea: a Phase 3b study;The Korean Journal of Internal Medicine;2023-07-01

3. Sofosbuvir–velpatasvir in adults with hepatitis C virus infection and compensated cirrhosis in Japan;Hepatology Research;2022-08-08

4. Pan-Genotypic Direct-Acting Antiviral Agents for Undetermined or Mixed-Genotype Hepatitis C Infection: A Real-World Multi-Center Effectiveness Analysis;Journal of Clinical Medicine;2022-03-27

5. Hepatitis C diagnosis slowdown in high-prevalence groups and using decentralised diagnostic strategies during the COVID-19 pandemic;Revista Española de Enfermedades Digestivas;2022